Lupeng Pharmaceutical
PrivateLast Round
Series B
Sep 1, 2025
Est. Valuation
$311M
Total Funding Raised
$160.2M
Company Overview
Lupeng Pharmaceutical is a clinical-stage biopharmaceutical company that discovers and develops innovative small molecule drugs for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lupeng Pharmaceutical Comparables
Compare Lupeng Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zentalis | 82% | |
| 成都海博为药业有限公司 | 82% | |
| InnoCare Pharma Limited | 80% |
Lupeng Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 1, 2025 | ||||
| Follow-on Offering | Nov 16, 2022 | ||||
| VC Round | Jul 27, 2021 | ||||
| Series A Extension | Jun 23, 2020 | ||||
| Series A | Jan 1, 2019 | ||||
Seed | Jun 27, 2018 |
Lupeng Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series A |
| Temasek | Series B, VC Round, Follow-on Offering |
| Lake Bleu Capital | VC Round, Follow-on Offering |
| Kaitai Capital | Seed, Series A Extension, Series B, Follow-on Offering |
| TF Capital | Series B |
| OrbiMed | Series B |
| Lilly Asia Ventures | VC Round, Series B, Follow-on Offering, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 16, 2022
$35M round led by Temasek and Kaitai Capital.
- Jul 27, 2021
$35M round led by Temasek
Lupeng Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lupeng Pharmaceutical's valuation, stock price, and market status.
Is Lupeng Pharmaceutical a public or private company?
Lupeng Pharmaceutical is a private company.
What is the current stock price of Lupeng Pharmaceutical?
Lupeng Pharmaceutical is a private company with no public stock price. No recent secondary market data is available.
How much is Lupeng Pharmaceutical worth (valuation)?
Valuation information for Lupeng Pharmaceutical is not publicly available.
Can I buy Lupeng Pharmaceutical stock?
Lupeng Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lupeng Pharmaceutical's last funding round?
Funding round information for Lupeng Pharmaceutical is not publicly available.
Who are the main investors in Lupeng Pharmaceutical?
Investor information for Lupeng Pharmaceutical is not publicly disclosed.
Will Lupeng Pharmaceutical IPO soon?
No public IPO plans have been announced for Lupeng Pharmaceutical.
How can I track Lupeng Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lupeng Pharmaceutical's secondary market activity and sign up for updates.